Pain Therapeutics, Inc. - Financial and Operations Review
Pain Therapeutics, Inc. - Financial and Operations Review - companiesandmarkets.com adds new report
© companiesandmarkets.com
27.11.2008 03:36:01 Pain Therapeutics, Inc. - SWOT Analysis - a new market research report on www.companiesandmarkets.com
(live-PR.com) - www.companiesandmarkets.com/Summary-Company-Prof ..
Datamonitor´s Pain Therapeutics, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company´s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Pain Therapeutics is a biopharmaceutical company that develops novel drugs for pain management and oncology. The
company has three investigational drug candidates in the clinical programs, namely: Remoxy, PTI-202 and Oxytrex. The company is also developing a novel radio-labeled monoclonal antibody to treat metastatic melanoma, a rare but deadly form of skin cancer. Pain Therapeutics is headquartered in San Francisco, California and employed 47 people as of December 2007. The company recorded revenues of $66 million during the financial year (FY) ended December 2007, an increase of 22.4% over 2006. The increase was mainly due to the amortization of milestone payments from King Pharmaceuticals under the strategic alliance to develop and commercialize Remoxy and other abuse-resistant opioid painkillers. The operating profit of the company was $10 million during FY2007, as compared to an operating loss of $1 million in 2006. The net profit was $20.3 million in FY2007, as compared to a net profit of $6 million in 2006.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company´s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers´ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors´ business structure, strategy and prospects
- Obtain the most up to date company information available
Datamonitor´s Pain Therapeutics, Inc. - SWOT Analysis company profile is the essential source for top-level company data and information. The report examines the company´s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Pain Therapeutics is a biopharmaceutical company that develops novel drugs for pain management and oncology. The
|
|
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company´s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers´ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors´ business structure, strategy and prospects
- Obtain the most up to date company information available
| Author: |
